T he bone marrow-derived B2 population represents the vast majority of bone marrow, blood, lymph node and splenic B-cells. Mouse B1 B-cells mostly originate during embryonic life in the liver and represent the main B-cell population in the pleural and peritoneal cavities. 1-5 B1 and B2 B-cells differ in their origin, antigen specificity, cell surface markers, tissue distribution and capacity for class switch recombination (CSR). Schematically, B1 B-cells appear earlier than B2 B-cells during fetal development and maintain their self-renewal ability throughout their life. Furthermore, they display a CSR biased toward IgA. [1] [2] [3] [4] [5] IgH cis-regulatory regions, especially transcriptional super-enhancers, are major locus regulators. 6 The IgH 3′ regulatory region (3′RR) super-enhancer promotes CSR in B2 B-cells. 7, 8 As B1 and B2 B-cells originate from different precursors and have clearly different development, function and regulation, we postulated that the 3′RR super-enhancer might differently regulate B1 and B2 B-cell IgA CSR.
The 3′RR super-enhancer plays a key regulatory role in B2 B-cell CSR by poising the S acceptor region for efficient recombination toward all isotypes 8 except IgD. 9, 10 Peritoneal cavity B1 B-cells switch preferentially to IgA. 11, 12 We thus investigated B1 B-cell IgA CSR in 3′RR-deficient mice. 7 Figure 1a , similar (P = 0.5) percentages of IgA + B1 B-cells were found in the peritoneal cavity of 3′RR-deficient and wild type (wt) mice in response to a pristane-induced local inflammatory reaction. Almost all recruited inflammatory B-cells in response to pristane had a B1 B-cell phenotype. We next investigated their ability to switch in vitro toward IgA (LPS+BAFF+TGFβ stimulation). As shown in Figure 1b , no difference (P = 0.3) was found in B1 B-cell IgA CSR between 3′RR-deficient mice and wt mice. Despite similar in vivo and in vitro IgA CSR, lowered (P = 0.0003) levels of IgA were found in peritoneal ascites of 3′RR-deficient mice compared with wt mice (Figure 1c ) and in IgA + cell culture supernatants (P = 0.002) of 3′RR-deficient B1 B-cells compared with wt B1 B-cells (Figure 1d ). q-PCR analysis indicated that the latter result originated from a significant (P = 0.01) decrease in I μ -C α transcripts in 3′RR-deficient mice compared with wt mice (Figure 1e ). Taken together, these results suggest that in contrast to B2 B-cells, 3′RR deletion did not affect the B1 B-cell CSR toward IgA but only decreased Cα transcription after CSR. The IgA-producing B1 B-cells contribute substantially to mucosal IgA production and thus play a key role in regulating commensal microbiota. 4, 14 We thus investigated IgA production in the intestinal tract of 3′RR-deficient mice and wt mice. Mouse feces were recovered and tested for the presence of IgA. We found a significant (P = 0.002) and marked (up to 99%) decrease in secreted IgA levels in feces of 3′RR-deficient mice (0.08 ± 0.03 μg/g, six mice) compared with wt mice (11.34 ± 0.63 μg/g, six mice IgA levels in the peritoneal cavity of pristane-treated 3′RR-deficient mice and wt mice. Same mice as in part A. ELISAs were performed as described. 7 Results are reported as the means ± s.e.m for eleven 3′RR-deficient mice and eight wt mice. (d) IgA levels in culture supernatants of IgA + B1 B-cells. Same mice as in part B. ELISAs were performed as described. 7 Results are reported as the means ± SEMs for twelve 3′RR-deficient mice and eleven wt mice. (e) q-PCR analysis of I μ -C α transcripts in cultured IgA + B1 B-cells from 3′RR-deficient mice and wt mice. q-PCR analyses of I μ -C α transcripts were performed as previously described. 8 ( Figure 1f ) and CD138 + (Figure 1g ) labeling in the intestinal tract of 3′RR-deficient mice and wt mice. Thus, similar to B2 B-cells, the 3′RR is of importance in B1 B-cells for the transcriptional burst associated with Ig synthesis and secretion by terminally differentiated switched plasma cells. In contrast to B2 B-cells, IgA CSR in B1 B-cells is 3′RR-independent. Previous results reported that this CSR in B1 B-cells is particularly unique because it occurs in minimal stimulatory conditions and is suppressed by the addition of stimuli that enhance B2 B-cell IgA CSR. 11 Moreover, B1 B-cell derived IgA is the most abundant Ig of the mucosal immune system. 15 Recently, efficient IgA CSR has been shown in the CH12F3 cell line in the absence of the 3′RR. 16 CH12F3 cells are derived from CH12 cells known to have a B1 B-cell phenotype, 17, 18 confirming our results concerning 3′RR-independent IgA CSR in B1 B-cells. Our data also supports differences in CSR control between B1 and B2 B-cells already described at the cytokine level. 11, 12, 15 Currently, the molecular CSR differences between B1 and B2 B-cells are unclear. If the 3′RR super-enhancer does not control IgA CSR, it controls IgA secretion via its key role in heavy chain transcription. 19 In conclusion, the evolution of the immune system occurs with overlaps between innate and adaptive immunity. B1 B-cells represent an early B-cell lineage, whereas B2 B-cells appear to have arisen later in evolution. The 3′RR superenhancer controls IgA CSR only in the specialized B2 B-cells, consolidating its involvement in adaptive immunology and indicating an evolution in the mechanism of CSR processes between B1 and B2 B-cells.
